Fasenra 30 mg solution for injection
- Licence status
- Active substances
- Benralizumab
- Dosage Form
- Solution for injection in pre-filled syringe
- Licence number
- EU/1/17/1252/001-002
- Licence holder
- AstraZeneca AB
Product documents
Licence information
- ATC code
- R03DX Other systemic drugs for obstructive airway diseases, R03DX10 benralizumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued